This extensive genetic mapping of DMD allowed us to draw various correlations between DMD/BMD genotype landscapes and variant frequency, variant types, variant locations along the gene, and their effects on population genetic characteristics, as well as new potential personalized dystrophinopathy therapies. This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.